Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Altalube
- Development stage
- Unknown
- Lead developer
- Altaire Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Ophthalmic, Topical
01
Overview
Altalube is an over-the-counter ophthalmic lubricant eye ointment developed and marketed by Altaire Pharmaceuticals for symptomatic relief of dry eye and ocular irritation. It is a topical small-molecule combination formulation containing mineral oil 15% and white petrolatum 85%, used as an ocular protectant and lubricant. Rather than acting through a specific molecular target, it works mechanically by coating the ocular surface and eyelid margin, reducing tear evaporation and friction, and providing a protective barrier that relieves dryness and irritation.
- Brand names
- Altalube
- Other names
- artificial tears eye ointmentmineral oil + white petrolatum ophthalmic ointment
Beyond the preview
Go deeper on Altalube.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Altalube.